stocksGVBL
0
GVBL

Genomic Valley Biotech Ltd.

30.39+1.4 (+4.79%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Genomic Valley Biotech Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Genomic Valley Biotech Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 30th June, 2026.
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Closure of trading window.
  • Newspaper Publication1 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith audited financial results for the quarter and year ended on 31 March 2026.
  • General29 May 2026
    To Consider And Approve The Appointment Of Mr. Navjyoti Kumar Jha As Internal Auditor Of The Company For The F.Y. 2026-27
    Appointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the F.Y. 2026-27.
  • Outcome of Board Meeting29 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (LODR) Regulation, 2015 Held On Friday 29Th May 2026.
    1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2026; 2. Considered and approved the appointment ....
  • Board Meeting18 May 2026
    Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited financial ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31st March, 2026.
  • General3 Apr 2026
    Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation, 2011
    Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ....
  • General1 Apr 2026
    Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation, 2011
    Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ....
  • Closure of Trading Window24 Mar 2026
    Closure of Trading Window
    Closure of Trading Window for the quarter and year ending on March 31, 2026.
  • Newspaper Publication17 Jan 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith unaudited financial results for the quarter and nine months ended on 31st December 2025.
  • Cessation15 Jan 2026
    Announcement under Regulation 30 (LODR)-Cessation
    Cessation of Mr. Ashok Kumar (DIN: 07647876) from the directorship of the company.
  • Outcome of Board Meeting15 Jan 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Dated 15-01-2026
    Please find enclosed herewith the Outcome of the Board Meeting dated 15/01/2026 for your reference.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jan 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31st December, 2025.
  • Board Meeting3 Jan 2026
    Board Meeting Intimation for Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
    Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 ,inter alia, to consider and approve the unaudited financial ....
  • AGM1 Jan 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of voting results of 31st Annual General Meeting of the Company under Regulation 44(3) of the SEBI (listing Obligations & Disclosure Requirements) Regulations, 2015.
  • AGM31 Dec 2025
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Please find enclosed herewith copy of proceeding of 31st Annual General Meeting of the company for your reference.
  • Closure of Trading Window29 Dec 2025
    Closure of Trading Window
    Please find enclosed herewith intimation of closure of trading window.
  • Newspaper Publication10 Dec 2025
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith Newspaper intimation for the 31st Annual General Meeting for your reference.
  • AGM9 Dec 2025
    Notice Of The Annual General Meeting
    Please find enclosed herewith the Notice of the Annual General Meeting for your reference.

Frequently Asked Questions

Where can I download the annual report of Genomic Valley Biotech Ltd.?
Annual reports of Genomic Valley Biotech Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Genomic Valley Biotech Ltd.?
Quarterly earnings results and presentations of Genomic Valley Biotech Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Genomic Valley Biotech Ltd. publish earnings call transcripts?
Earnings call transcripts of Genomic Valley Biotech Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Genomic Valley Biotech Ltd.?
Investor presentations and annual day presentations of Genomic Valley Biotech Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Genomic Valley Biotech Ltd.?
Corporate announcements and regulatory filings of Genomic Valley Biotech Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Genomic Valley Biotech Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Genomic Valley Biotech Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Genomic Valley Biotech Ltd.?
The ISIN (International Securities Identification Number) of Genomic Valley Biotech Ltd. is INE574D01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Genomic Valley Biotech Ltd. listed?
Genomic Valley Biotech Ltd. is listed on NSE and BSE. The NSE symbol is GVBL and the BSE code is -.
Where can I find the shareholding pattern of Genomic Valley Biotech Ltd.?
The quarterly shareholding pattern of Genomic Valley Biotech Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Genomic Valley Biotech Ltd. on Sharpely?
Share price data for Genomic Valley Biotech Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.